CN1236619A - Contraceptive - Google Patents
Contraceptive Download PDFInfo
- Publication number
- CN1236619A CN1236619A CN 98113570 CN98113570A CN1236619A CN 1236619 A CN1236619 A CN 1236619A CN 98113570 CN98113570 CN 98113570 CN 98113570 A CN98113570 A CN 98113570A CN 1236619 A CN1236619 A CN 1236619A
- Authority
- CN
- China
- Prior art keywords
- contraceptive
- povidone iodine
- major ingredient
- adjuvant
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A new contraceptive in the form of external application cream or suppository features that it mainly contains iodophor for killing spermia and bacteria. Its advantages are no poison and damage to human body and no by-effect.
Description
The invention belongs to a kind of novel contraceptive.
Though it is multiple that existing contraceptive has, what generally use is the Np-9 nonoxynolum, and it kills effective, the no negative interaction of sperm.But, in based on its contraceptive, all must add the effect that other compositions reach sterilizing because Np-9 itself does not have the effect of sterilizing.
The object of the present invention is to provide a kind of novel contraceptive, it can effectively kill sperm, and has the effect of sterilizing, and a kind of new alternative contraceptive of killing sperm is provided simultaneously.
Novel contraceptive medicine of the present invention is characterized in that it consists predominantly of povidone iodine.
As above-mentioned contraceptive, it is characterized in that the parts by weight of major ingredient and adjuvant are as follows:
Major ingredient: povidone iodine (available iodine) 0.2～4
Adjuvant: PEG400 50～90
Macrogol 4000 50～90
Distilled water 2～80
Essence is an amount of.
As above-mentioned contraceptive, it is characterized in that also having: sodium lauryl sulphate 1～6, potassium iodate 1～5.
Contraceptive of the present invention is the external type, can be paste or bolt shape, perhaps other dosage form.Povidone iodine is extensive use of as a kind of general disinfection product, to human body is safe, and to kill the sperm effect very good for major ingredient with it, can substitute Np-9 fully and independently use, overcome the deficiencies in the prior art, we have had a kind of new alternative contraceptive again simultaneously.
Embodiment one (unguentum)
1. prescription: 1. povidone iodine 0.2g
2. PEG400 5g
3. Macrogol 4000 5g
4. distilled water 0.8g
5. sodium lauryl sulphate 0.1g
6. potassium iodate 0.1g
7. essence is an amount of.2, method for making: 1) get 2. and 3. put in the beaker, 50 ℃ of water-bath fusions;
2) get 5. and 6. place beaker to add 4. dissolving, 1. 50 ℃ of heating in water bath add again, stir and make dissolving;
3) with 1) slow pour 2 into) in, stir until being cooled to room temperature, add 7. an amount of.Embodiment two (suppository) 1, prescription: 1. povidone iodine 0.2g
2. distilled water 0.2g
3. PEG400 5g
4. Macrogol 4000 5g
5. essence is an amount of.2, method for making: 1) get 1. to be dissolved in and 2. be heated to 50 ℃;
2) get 3. and 4. put in the heat cup, 50 ℃ of water-bath fusions;
3) with 1) delay and pour 2 into) in, pulverize with colloid mill or homogenizer;
4) pour the mold cools down molding into, make ten.
Claims (3)
1, a kind of novel contraceptive is characterized in that it consists predominantly of povidone iodine.
2, contraceptive as claimed in claim 1 is characterized in that the parts by weight of major ingredient and adjuvant are as follows:
Major ingredient: povidone iodine (available iodine) 0.2～4
Adjuvant: PEG400 50～90
Macrogol 4000 50～90
Distilled water 2～80
Essence is an amount of.
3, contraceptive as claimed in claim 2 is characterized in that also having: sodium lauryl sulphate 1～6, potassium iodate 1～5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98113570 CN1236619A (en) | 1998-05-27 | 1998-05-27 | Contraceptive |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98113570 CN1236619A (en) | 1998-05-27 | 1998-05-27 | Contraceptive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1236619A true CN1236619A (en) | 1999-12-01 |
Family
ID=5223286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 98113570 Pending CN1236619A (en) | 1998-05-27 | 1998-05-27 | Contraceptive |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1236619A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012092776A1 (en) * | 2011-01-07 | 2012-07-12 | 上海宇昂化工科技发展有限公司 | High-stability non-ionic n-vinylbutyrolactam iodide solution and related formulation method therefor |
| CN102885852A (en) * | 2012-10-23 | 2013-01-23 | 武汉迪奥药业有限公司 | Povidone iodine ointment and preparation method thereof |
| WO2014183314A1 (en) * | 2013-05-17 | 2014-11-20 | Song Bo | New application of povidone iodine |
-
1998
- 1998-05-27 CN CN 98113570 patent/CN1236619A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012092776A1 (en) * | 2011-01-07 | 2012-07-12 | 上海宇昂化工科技发展有限公司 | High-stability non-ionic n-vinylbutyrolactam iodide solution and related formulation method therefor |
| CN102885852A (en) * | 2012-10-23 | 2013-01-23 | 武汉迪奥药业有限公司 | Povidone iodine ointment and preparation method thereof |
| WO2014183314A1 (en) * | 2013-05-17 | 2014-11-20 | Song Bo | New application of povidone iodine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60204142T2 (en) | PREPARATIONS WITH OLOPATADIN FOR TOPICAL APPLICATION | |
| US4788060A (en) | Multiple electrolyte douche and wipe composition | |
| US6048553A (en) | Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases | |
| RU2008102510A (en) | COMPOSITIONS FOR LOCAL USE FOR TREATMENT OF SKIN DISEASES | |
| CA2251982C (en) | Ophthalmic compound with extended dwell time on the eye | |
| US4505924A (en) | Pharmaceutical preparation for the topical treatment of acne | |
| CN102559408A (en) | Pure plant type antibacterial cleanser and preparation method thereof | |
| CN103385926A (en) | Antibiosis gel for curing cervical and vaginal diseases of gynaecology | |
| CN106109451A (en) | A kind of antibiotic preparation and preparation method thereof | |
| CN104824050A (en) | Corrosion-resistant medical equipment disinfectant | |
| JPH1160505A (en) | Antiseptic composition | |
| CN110029026A (en) | A kind of sterilizing and itch-relieving medicated soap and preparation method thereof | |
| CN1236619A (en) | Contraceptive | |
| CN113729033B (en) | Chlorine-containing disinfectant with high thermal stability and preparation method thereof | |
| US6436417B1 (en) | Acne treatment compositions | |
| Lloyd et al. | Essential fatty acid supplementation in the treatment of canine atopy: a preliminary study | |
| SK279195B6 (en) | Pharmaceutical enema preparation | |
| EP2814848B1 (en) | Partially depolymerized glycosaminoglycan silver and gold salts | |
| AU673724B2 (en) | Wound-healing compositions containing iodine and a non-reducing sugar | |
| DE60029571T2 (en) | Preparations based on chondroitin sulfate and chitosan for the preparation of compositions for the prevention or treatment of rheumatic diseases | |
| CN113143992A (en) | Skin antibacterial cream and preparation method thereof | |
| CN111249168A (en) | Composition for preventing mosquito bites and preparation method thereof | |
| CN111888406A (en) | Chinese medicine preparation widely used for epidermic inflammation and preparation method thereof | |
| CN1257116A (en) | Medicated soap with functions of tonifying skin and disinfection | |
| CN107854471A (en) | A kind of pharmaceutical preparation and purposes for treating cervical erosion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address of the applicant after: Building 19, No. 3, Guang eight road, Wuchang District, Wuhan, Hubei Address of the applicant before: No 44, Middle District, Hongshan, Wuhan, Hubei, Wuchang |
|
| CB03 | Change of inventor or designer information |
Inventor after: Wang Chunsheng Inventor after: Wu Jing Inventor after: Lin Yuantong Inventor before: Lin Yuantong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIN YUANTONG TO: WANG CHUNSHENG; WU JING; LIN YUANTONG |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |